CXC chemokines in angiogenesis

Cytokine Growth Factor Rev. 2005 Dec;16(6):593-609. doi: 10.1016/j.cytogfr.2005.04.007. Epub 2005 Jul 19.


CXC chemokines display pleiotropic effects in immunity, regulating angiogenesis, and mediating organ-specific metastases of cancer. In the context of angiogenesis, CXC chemokines are a unique family of cytokines, known for their ability to behave in a disparate manner in the regulation of angiogenesis. Members that contain the 'ELR' motif are potent promoters of angiogenesis, and mediate their angiogenic activity via binding and activating CXCR2 on endothelium. In contrast, members, in general, those are inducible by interferons and lack the ELR motif (ELR-) are potent inhibitors of angiogenesis, and bind to CXCR3 on endothelium. This review will discuss the biology of these angiogenic and angiostatic CXC chemokines and discuss their disparate angiogenic activity in the context of a variety of disorders.

Publication types

  • Research Support, N.I.H., Extramural
  • Review

MeSH terms

  • Angiogenesis Modulating Agents / pharmacology
  • Animals
  • Chemokines, CXC / analysis
  • Chemokines, CXC / physiology*
  • Humans
  • Immune System Diseases / etiology
  • Neovascularization, Physiologic / drug effects
  • Neovascularization, Physiologic / physiology*
  • Receptors, Chemokine / metabolism*
  • T-Lymphocytes / immunology


  • Angiogenesis Modulating Agents
  • Chemokines, CXC
  • Receptors, Chemokine